Studying heart disease using the proteomic approach

Dunn1

  • 1Department of Cardiothoracic Surgery, National Heart and Lung Institute, Imperial College School of Medicine, Heart Science Centre, Harefield Hospital, Harefield, Middlesex, UK UB9 6JH.

Drug Discovery Today
|February 1, 2000
PubMed

Insights

Understanding heart disease mechanisms is crucial. Proteomics reveals global protein changes in cardiac dysfunction, offering new diagnostic and therapeutic avenues for heart conditions.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Proteomics

Background:

  • Pathogenic mechanisms of cardiac dysfunction in heart disease remain largely unknown.
  • Alterations in myocardial gene and protein expression are implicated in disease progression.
  • Previous molecular studies focused on specific cellular systems.

Purpose of the Study:

  • To characterize global alterations in protein expression in heart disease using proteomics.
  • To gain new insights into the cellular mechanisms of cardiac dysfunction.
  • To identify novel diagnostic markers and therapeutic opportunities for heart disease.

Main Methods:

  • Application of the proteomic approach to study heart disease.
  • Characterization of global protein expression alterations.
  • Analysis of molecular changes in myocardial tissue.

Main Results:

  • Proteomics enables the characterization of global protein expression changes in cardiac dysfunction.
  • This approach provides a comprehensive view of molecular alterations.
  • Identified changes offer potential for new diagnostic and therapeutic strategies.

Conclusions:

  • Proteomics is a powerful tool for understanding the molecular basis of cardiac dysfunction.
  • Global protein expression analysis promises significant advancements in heart disease research.
  • This approach is expected to lead to novel diagnostic markers and therapeutic interventions for heart conditions.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...